UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 22, 2025
Accession Number:
0001193125-25-326992
Submission Type:
POS AM
CIK:
0001075880
Company Name:
KAZIA THERAPEUTICS LTD
File Number:
333-276774